Eledon Pharmaceuticals (ELDN) Short Interest Ratio & Short Volume $2.95 -0.05 (-1.67%) (As of 07/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Eledon Pharmaceuticals Short Interest DataCurrent Short Interest128,800 sharesPrevious Short Interest170,600 sharesChange Vs. Previous Month-24.50%Dollar Volume Sold Short$336,168.00Short Interest Ratio0.6 Days to CoverLast Record DateJuly 15, 2024Outstanding Shares24,813,000 sharesPercentage of Shares Shorted0.52%Today's Trading Volume53,644 sharesAverage Trading Volume142,486 sharesToday's Volume Vs. Average38% Short Selling Eledon Pharmaceuticals ? Sign up to receive the latest short interest report for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartELDN Short Interest Over TimeELDN Days to Cover Over TimeELDN Percentage of Float Shorted Over Time Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Eledon Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/15/2024128,800 shares $336,168.00 -24.5%N/A0.6 $2.61 6/30/2024170,600 shares $450,384.00 +225.6%N/A0.8 $2.64 6/15/202452,400 shares $158,772.00 +7.4%N/A0.2 $3.03 5/31/202448,800 shares $134,200.00 -74.5%N/A0.2 $2.75 5/15/2024191,500 shares $479,707.50 +441.0%N/A1 $2.51 4/30/202435,400 shares $84,606.00 +13.8%N/A0.2 $2.39 Get the Latest News and Ratings for ELDN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eledon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 4/15/202431,100 shares $51,004.00 -70.9%N/A0.3 $1.64 3/31/2024106,900 shares $220,214.00 +193.7%N/A1.4 $2.06 3/15/202436,400 shares $56,056.00 -6.7%N/A0.5 $1.54 2/29/202439,000 shares $70,200.00 -26.7%N/A0.6 $1.80 2/15/202453,200 shares $97,356.00 -11.8%N/A0.8 $1.83 1/31/202460,300 shares $107,334.00 -15.6%N/A0.8 $1.78 1/15/202471,400 shares $123,529.14 +37.3%N/A0.8 $1.73 12/31/202352,000 shares $93,600.00 -20.4%N/A0.6 $1.80 12/15/202365,300 shares $99,256.00 +147.4%N/A0.7 $1.52 11/30/202326,400 shares $30,360.00 -59.9%N/A0.3 $1.15 11/15/202365,900 shares $82,375.00 +25.8%N/A0.7 $1.25 10/31/202352,400 shares $81,744.00 +5.2%N/A0.6 $1.56 10/15/202349,800 shares $73,704.00 -20.1%N/A0.7 $1.48 9/30/202362,300 shares $85,351.00 +92.3%N/A0.9 $1.37 9/15/202332,400 shares $40,500.00 +18.7%N/A0.6 $1.25 8/31/202327,300 shares $41,496.00 -34.4%N/A0.5 $1.52 8/15/202341,600 shares $50,752.00 +1.2%N/A0.5 $1.22 7/31/202341,100 shares $56,718.00 +18.1%N/A0.3 $1.38 7/15/202334,800 shares $50,112.00 -4.1%N/A0.2 $1.44 6/30/202336,300 shares $49,731.00 -85.1%N/A0.2 $1.37 6/15/2023244,200 shares $402,930.00 +383.6%2.0%1.3 $1.65 5/31/202350,500 shares $106,050.00 +136.0%0.4%0.3 $2.10 5/15/202321,400 shares $49,648.00 -62.6%0.2%0.1 $2.32 4/30/202357,200 shares $120,120.00 +276.3%0.4%0.5 $2.10 4/15/202315,200 shares $37,088.00 -47.0%0.1%0.6 $2.44 3/31/202328,700 shares $67,732.00 +64.9%0.2%1.1 $2.36 3/15/202317,400 shares $34,974.00 +4.2%0.1%0.8 $2.01 2/28/202316,700 shares $39,412.00 -9.2%0.1%1 $2.36 2/15/202318,400 shares $49,864.00 +8.2%0.1%1.2 $2.71 1/31/202317,000 shares $56,440.00 +6.3%0.1%1.1 $3.32 1/15/202316,000 shares $45,561.60 +11.9%0.1%1.1 $2.85 12/30/202214,300 shares $32,604.00 +19.2%0.1%0.7 $2.28 12/15/202212,000 shares $28,972.80 -39.7%0.1%0.6 $2.41 11/30/202219,900 shares $48,556.00 -20.1%0.1%1 $2.44New trading system called MSFT, NVDA & MSFT (Ad)Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! 11/15/202224,900 shares $65,736.00 +69.4%0.2%1.1 $2.64 10/31/202214,700 shares $35,427.00 -2.0%0.1%0.6 $2.41 10/15/202215,000 shares $37,992.00 -29.9%0.1%0.6 $2.53 9/30/202221,400 shares $59,064.00 -4.9%0.2%0.7 $2.76 9/15/202222,500 shares $76,500.00 -17.6%0.2%0.7 $3.40 8/31/202227,300 shares $102,375.00 +31.3%0.2%0.5 $3.75 8/15/202220,800 shares $73,632.00 +181.1%0.2%0.3 $3.54 7/31/20227,400 shares $22,274.00 -10.8%0.1%0.1 $3.01 7/15/20228,300 shares $24,900.00 +31.8%0.1%0.1 $3.00 6/30/20226,300 shares $15,372.00 -84.9%0.1%0.1 $2.44 6/15/202241,600 shares $122,304.00 +4.3%0.3%0.8 $2.94 5/31/202239,900 shares $127,281.00 +250.0%0.3%0.9 $3.19 5/15/202211,400 shares $30,220.26 -22.5%0.1%0.4 $2.65 4/30/202214,700 shares $44,982.00 +107.0%0.1%0.5 $3.06 4/15/20227,100 shares $21,513.00 -93.9%0.1%0.2 $3.03 3/31/2022115,700 shares $455,858.00 -6.5%N/A1.5 $3.94 3/15/2022123,700 shares $379,759.00 -12.6%0.9%1.5 $3.07 2/28/2022141,600 shares $499,848.00 -23.0%1.0%1.5 $3.53 2/15/2022184,000 shares $772,800.00 +6.6%1.3%1.9 $4.20 1/31/2022172,600 shares $699,030.00 +39.2%1.2%1.6 $4.05 1/15/2022124,000 shares $549,320.00 +1.8%N/A0 $4.43 12/31/2021121,800 shares $537,138.00 -12.0%0.9%1.6 $4.41 12/15/2021138,400 shares $596,504.00 -21.5%1.0%1.8 $4.31 11/30/2021176,400 shares $862,596.00 -1.7%1.2%2.1 $4.89 11/15/2021179,500 shares $998,020.00 -15.7%1.3%2.2 $5.56 10/29/2021212,900 shares $1.06 million +14.0%1.5%2.7 $5.00 10/15/2021186,700 shares $1.05 million -26.0%1.3%2.5 $5.63 9/30/2021252,300 shares $1.56 million +89.8%1.8%3.1 $6.18 9/15/2021132,900 shares $930,300.00 +0.2%0.9%1.8 $7.00 8/31/2021132,600 shares $1.10 million -5.6%0.9%1.9 $8.32 8/13/2021140,500 shares $878,125.00 -15.0%1.0%2.1 $6.25 7/30/2021165,300 shares $1.07 million -64.0%1.2%2.9 $6.49 7/15/2021459,000 shares $3.28 million -2.7%3.2%8.9 $7.14 6/30/2021471,900 shares $3.73 million +187.0%3.3%11.9 $7.91 6/15/2021164,400 shares $1.34 million -5.2%1.2%3.5 $8.15 5/28/2021173,500 shares $1.65 million -11.6%1.2%3.6 $9.52 5/14/2021196,200 shares $1.73 million -4.5%1.4%3.6 $8.80 4/30/2021205,400 shares $2.05 million -4.5%1.4%3.3 $9.96 4/15/2021215,000 shares $2.46 million +17.0%N/A0 $11.43 3/31/2021183,700 shares $1.81 million +22.0%1.3%2.7 $9.85 3/15/2021150,600 shares $2.08 million +8.0%13.9%2.1 $13.81 2/26/2021139,400 shares $2.30 million +23.9%12.9%2.4 $16.50 2/12/2021112,500 shares $2.13 million +20.7%10.4%2.4 $18.94 1/29/202193,200 shares $1.35 million +6.4%8.6%2.2 $14.53 1/15/202187,600 shares $1.25 million No Change8.1%2.1 $14.25 ELDN Short Interest - Frequently Asked Questions What is Eledon Pharmaceuticals' current short interest? Short interest is the volume of Eledon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 128,800 shares of ELDN short. Learn More on Eledon Pharmaceuticals' current short interest. What is a good short interest ratio for Eledon Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ELDN shares currently have a short interest ratio of 1.0. Learn More on Eledon Pharmaceuticals's short interest ratio. Is Eledon Pharmaceuticals' short interest increasing or decreasing? Eledon Pharmaceuticals saw a decrease in short interest in July. As of July 15th, there was short interest totaling 128,800 shares, a decrease of 24.5% from the previous total of 170,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Eledon Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Eledon Pharmaceuticals: Zentalis Pharmaceuticals, Inc. (14.67%), Nektar Therapeutics (5.44%), CorMedix Inc. (18.85%), Zevra Therapeutics, Inc. (7.63%), Foghorn Therapeutics Inc. (4.01%), Atai Life Sciences (7.95%), Nanobiotix S.A. (0.11%), Mersana Therapeutics, Inc. (7.82%), Gossamer Bio, Inc. (4.06%), Design Therapeutics, Inc. (9.20%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks. What does it mean to sell short Eledon Pharmaceuticals stock? Short selling ELDN is an investing strategy that aims to generate trading profit from Eledon Pharmaceuticals as its price is falling. ELDN shares are trading down $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Eledon Pharmaceuticals? A short squeeze for Eledon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ELDN, which in turn drives the price of the stock up even further. How often is Eledon Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ELDN, twice per month. The most recent reporting period available is July, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Zentalis Pharmaceuticals Short Interest Data Nektar Therapeutics Short Interest Data CorMedix Short Interest Data Zevra Therapeutics Short Interest Data Foghorn Therapeutics Short Interest Data Atai Life Sciences Short Interest Data Nanobiotix Short Interest Data Mersana Therapeutics Short Interest Data Gossamer Bio Short Interest Data Design Therapeutics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ELDN) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.